BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 288 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $146,625,000 | -17.2% | 1,236,609 | -3.7% | 0.66% | -0.3% |
| Q4 2021 | $177,028,000 | +1.4% | 1,284,580 | +2.2% | 0.66% | -6.9% |
| Q3 2021 | $174,537,000 | +100.7% | 1,256,472 | +40.3% | 0.71% | +88.6% |
| Q2 2021 | $86,958,000 | +47.6% | 895,732 | +3.9% | 0.38% | +3.6% |
| Q1 2021 | $58,906,000 | -14.4% | 861,827 | +7.4% | 0.36% | -12.5% |
| Q4 2020 | $68,785,000 | – | 802,527 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |